GMP Engineering & Owner Representative Services

We manage the design, construction and commissioning of high-tech pharmaceutical and biotech facilities. 20+ years of experience, 600+ global projects.


Core Services

Comprehensive GMP engineering and consulting solutions for pharmaceutical and biotech facilities

GMP

Facility Design

From concept to detailed design, ensuring compliance with PIC/S GMP and FDA regulations.

Cell Therapy

 Facilities

Specialized design and engineering for advanced therapy manufacturing.

Computer System

Validation

FDA 21 CFR Part 11 compliant validation for critical manufacturing systems.

Owner

Representative

Comprehensive project oversight and management to protect your interests throughout the facility lifecycle.

Services

Why Choose  Persimmon Engineering

Deep Industry Expertise

Two decades of hands-on experience in GMP facility engineering and owner representation.

Proven Track Record

Successfully delivered 600+ projects for leading pharmaceutical and biotech companies.

Local & Global Presence

Taiwan-based with international offices, combining local market knowledge with global best practices.

Flexible Resources

Scalable team structure to support projects of any size and complexity.

quotesArtboard 1 copy 2

Comprehensive owner representation for a $50M pharmaceutical manufacturing facility expansion including design review, construction supervision, and commissioning support.

Pfizer Hangzhou

Owner Representative

 Trends & Insights

GMP Regulations and Pharmaceutical Engineering

By Austin Chuang May 6, 2026
Discover the ultimate step-by-step guide to Good Documentation Practice (GDP) in GMP environments. Learn ALCOA+ principles, data integrity, and CSV compliance.
By Austin Chuang May 6, 2026
Discover how ATMP compliance impacts your bottom line. A deep dive for executives on navigating regulatory risks, the RBA, and ensuring lifetime traceability.
By Austin Chuang April 30, 2026
A regulatory auditor's guide to the FDA's first AI warning letter (Purolea). Explore 21 CFR compliance, QCU human-in-the-loop controls, and physical GMP risks.